Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of $5.62 million. The enterprise value is $4.01 million.

Market Cap	5.62M
Enterprise Value	4.01M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Genprex has 24.15 million shares outstanding. The number of shares has increased by 192.89% in one year.

Current Share Class	24.15M
Shares Outstanding	24.15M
Shares Change (YoY)	+192.89%
Shares Change (QoQ)	+149.41%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	1.75%
Float	24.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.56
P/TBV Ratio	3.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.83

Current Ratio	0.83
Quick Ratio	0.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -473.37% and return on invested capital (ROIC) is -292.90%.

Return on Equity (ROE)	-473.37%
Return on Assets (ROA)	-178.90%
Return on Invested Capital (ROIC)	-292.90%
Return on Capital Employed (ROCE)	-1,306.92%
Revenue Per Employee	n/a
Profits Per Employee	-$1.43M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.25% in the last 52 weeks. The beta is -0.39, so Genprex's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-89.25%
50-Day Moving Average	0.34
200-Day Moving Average	0.88
Relative Strength Index (RSI)	38.73
Average Volume (20 Days)	7,246,537

Short Selling Information

The latest short interest is 277,360, so 1.15% of the outstanding shares have been sold short.

Short Interest	277,360
Short Previous Month	333,583
Short % of Shares Out	1.15%
Short % of Float	1.15%
Short Ratio (days to cover)	0.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.17M
Pretax Income	-27.63M
Net Income	-21.39M
EBITDA	-21.17M
EBIT	-21.17M
Earnings Per Share (EPS)	-$5.34

Full Income Statement

Balance Sheet

The company has $1.60 million in cash and n/a in debt, giving a net cash position of $1.60 million or $0.07 per share.

Cash & Cash Equivalents	1.60M
Total Debt	n/a
Net Cash	1.60M
Net Cash Per Share	$0.07
Equity (Book Value)	1.62M
Book Value Per Share	0.15
Working Capital	-426,703

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.15M
Capital Expenditures	n/a
Free Cash Flow	-17.15M
FCF Per Share	-$0.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-192.89%
Shareholder Yield	-192.89%
Earnings Yield	-380.88%
FCF Yield	-305.39%

Analyst Forecast

The average price target for Genprex is $10.00, which is 4,201.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	4,201.08%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 0.025:1.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	0.025:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1